For 24 years Leonard George Goodwin was responsible for developing
chemotherapeutic agents against parasites at what became the Wellcome
Laboratories of Tropical Medicine. Having degrees in pharmacy, physiology and,
eventually, clinical medicine, he was active from the start of World War II in
the drive to protect Allied forces in the field from tropical diseases. It was
in the 1940s, 1950s and into the 1960s that Goodwin had most immediate and
lasting impact, through the establishment of five major drugs: sodium
stibogluconate, for treatment of leishmaniasis; pyrimethamine, for malaria;
piperazine, to combat ascariasis; bephenium, for ankylostomiasis; and
phenanthridine derivates, to treat trypanosomiasis. Such agents also became
important in veterinary medicine. In 1963 he became director of the new Nuffield
Institute of Comparative Medicine and then director of science at the Zoological
Society of London. Although Goodwin never worked in higher education, he
nonetheless influenced many careers through his involvement with scientific
societies.